Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Exosome removal as a therapeutic adjuvant in cancer.

Marleau AM, Chen CS, Joyce JA, Tullis RH.

J Transl Med. 2012 Jun 27;10:134. doi: 10.1186/1479-5876-10-134.

2.

Exosomes as a tumor immune escape mechanism: possible therapeutic implications.

Ichim TE, Zhong Z, Kaushal S, Zheng X, Ren X, Hao X, Joyce JA, Hanley HH, Riordan NH, Koropatnick J, Bogin V, Minev BR, Min WP, Tullis RH.

J Transl Med. 2008 Jul 22;6:37. doi: 10.1186/1479-5876-6-37.

3.

Increasing vaccine potency through exosome antigen targeting.

Hartman ZC, Wei J, Glass OK, Guo H, Lei G, Yang XY, Osada T, Hobeika A, Delcayre A, Le Pecq JB, Morse MA, Clay TM, Lyerly HK.

Vaccine. 2011 Nov 21;29(50):9361-7. doi: 10.1016/j.vaccine.2011.09.133. Epub 2011 Oct 12.

4.

Exosomes for the treatment of human malignancies.

Viaud S, Ullrich E, Zitvogel L, Chaput N.

Horm Metab Res. 2008 Feb;40(2):82-8. doi: 10.1055/s-2007-1022548. Review.

PMID:
18283625
5.

Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments.

Taylor DD, Gercel-Taylor C.

Semin Immunopathol. 2011 Sep;33(5):441-54. doi: 10.1007/s00281-010-0234-8. Epub 2011 Jun 19. Review.

PMID:
21688197
6.

Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials.

Vlassov AV, Magdaleno S, Setterquist R, Conrad R.

Biochim Biophys Acta. 2012 Jul;1820(7):940-8. doi: 10.1016/j.bbagen.2012.03.017. Epub 2012 Apr 1. Review.

PMID:
22503788
7.

The roles of tumor-derived exosomes in cancer pathogenesis.

Yang C, Robbins PD.

Clin Dev Immunol. 2011;2011:842849. doi: 10.1155/2011/842849. Epub 2011 Nov 30. Review.

8.

Tumor-derived exosomes as mediators of disease and potential diagnostic biomarkers.

Roberson CD, Atay S, Gercel-Taylor C, Taylor DD.

Cancer Biomark. 2010-2011;8(4-5):281-91. doi: 10.3233/CBM-2011-0211.

PMID:
22045359
9.

Exosomes as intercellular signalosomes and pharmacological effectors.

Record M, Subra C, Silvente-Poirot S, Poirot M.

Biochem Pharmacol. 2011 May 15;81(10):1171-82. doi: 10.1016/j.bcp.2011.02.011. Epub 2011 Mar 1. Review.

PMID:
21371441
10.

Exosomes and the MICA-NKG2D system in cancer.

Clayton A, Tabi Z.

Blood Cells Mol Dis. 2005 May-Jun;34(3):206-13.

PMID:
15885603
11.

The application of exosomes as a nanoscale cancer vaccine.

Tan A, De La Peña H, Seifalian AM.

Int J Nanomedicine. 2010 Nov 10;5:889-900. doi: 10.2147/IJN.S13402. Review.

12.

Cancer immunotherapy using dendritic cell-derived exosomes.

Amigorena S.

Medicina (B Aires). 2000;60 Suppl 2:51-4.

PMID:
11188932
13.

Exosome signaling in mammary gland development and cancer.

Hendrix A, Hume AN.

Int J Dev Biol. 2011;55(7-9):879-87. doi: 10.1387/ijdb.113391ah. Review.

14.

Tumour-derived exosomes: Tiny envelopes for big stories.

Miller IV, Grunewald TG.

Biol Cell. 2015 Sep;107(9):287-305. doi: 10.1111/boc.201400095. Epub 2015 Jun 9. Review.

PMID:
25923825
15.

Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy.

Rountree RB, Mandl SJ, Nachtwey JM, Dalpozzo K, Do L, Lombardo JR, Schoonmaker PL, Brinkmann K, Dirmeier U, Laus R, Delcayre A.

Cancer Res. 2011 Aug 1;71(15):5235-44. doi: 10.1158/0008-5472.CAN-10-4076. Epub 2011 Jun 13.

16.

Microenvironmental pH is a key factor for exosome traffic in tumor cells.

Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, De Milito A, Coscia C, Iessi E, Logozzi M, Molinari A, Colone M, Tatti M, Sargiacomo M, Fais S.

J Biol Chem. 2009 Dec 4;284(49):34211-22. doi: 10.1074/jbc.M109.041152. Epub 2009 Sep 30.

17.

[Tumour-derived exosomes and their roles in cancer].

Wang K, Tang J.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Dec;35(12):1288-92. doi: 10.3969/j.issn.1672-7347.2010.12.015. Review. Chinese.

18.

Hypoxic enhancement of exosome release by breast cancer cells.

King HW, Michael MZ, Gleadle JM.

BMC Cancer. 2012 Sep 24;12:421. doi: 10.1186/1471-2407-12-421.

19.

Dark side of the exosome: the role of the exosome in cancer metastasis and targeting the exosome as a strategy for cancer therapy.

Kosaka N, Yoshioka Y, Tominaga N, Hagiwara K, Katsuda T, Ochiya T.

Future Oncol. 2014 Mar;10(4):671-81. doi: 10.2217/fon.13.222. Review.

PMID:
24754596
20.

Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC.

Battke C, Ruiss R, Welsch U, Wimberger P, Lang S, Jochum S, Zeidler R.

Cancer Immunol Immunother. 2011 May;60(5):639-48. doi: 10.1007/s00262-011-0979-5. Epub 2011 Feb 4.

PMID:
21293856
Items per page

Supplemental Content

Write to the Help Desk